Coloplast

DenmarkFounded 195711–50 employeescoloplast.comLinkedIn

Coloplast is a Denmark-founded medical technology company that develops products and services for people with intimate healthcare needs. Its portfolio spans ostomy, continence, bowel, voice and respiratory care, wound and tissue repair, and interventional urology, supporting more than two million people worldwide.

Visit coloplast.com ↗

Founded: 1957
Employees: 11–50

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Sep 2026

Recent highlights

Coloplast has strengthened its commercial reach through a new Vizient technology contract for its Biatain silicone fit wound care product and a Medtronic distribution agreement covering Asia-Pacific. The company is also advancing its product pipeline, including an upgraded antimicrobial urinary catheter and the planned U.S. launch of the Titan Prime inflatable penile implant in the second half of 2026. Recent executive changes include Gavin Wood becoming CEO and Amanda Rajkumar joining as Chief People Officer.

Market position

Coloplast operates in specialized medical device markets spanning ostomy, continence, wound care, and erectile dysfunction, with a portfolio focused on clinically complex and long-term care needs. Its product differentiation is centered on specialized catheter, implant, and advanced wound care technologies, including antimicrobial and biofilm-management capabilities.

Growth & opportunities

Coloplast shows ongoing growth activity through new product launches, clinical development, FDA-enabled commercialization plans, and expanded distribution in Asia-Pacific. Partnerships with Vizient and Medtronic could broaden access to its wound care and continence products, while leadership appointments suggest organizational change alongside continued investment in innovation. These initiatives may create opportunities across product development, clinical affairs, regulatory, commercial, and international operations.

Written by reccy's AI from company sites, press and funding records · updated Sep 2026

What makes Coloplast distinct

reccy insights

What makes Coloplast distinct

01Nearly seven decades of innovation rooted in empathy, beginning with the world’s first ostomy bag in 1957.
02Broad global portfolio addressing chronic and intimate healthcare needs across six specialist business areas.
03Products and services are developed through close collaboration with users, healthcare professionals, payers, and healthcare systems.
04Global scale with more than 17,000 employees across 43 countries and products sold in more than 140 countries.
05Strong focus on sustainability, including recyclable packaging, renewable materials, eco-design, and a target to reduce product and packaging materials by 15–20% by 2030.

Technology & products6

Technology & products

Ostomy Care
Ostomy bags and supporting products for people living with a stoma, designed to manage bodily output and help protect the skin around the stoma.
Continence Care
Intermittent catheters and urinary collecting devices for people managing urinary retention or urinary incontinence.
Advanced Wound Dressings
Foam, fiber, and hydrocolloid dressings for managing exudate and treating acute, chronic, and hard-to-heal wounds.
Voice and Respiratory Care
Voice prostheses, heat-moisture exchangers, tubes, adhesives, speaking valves, and related devices for laryngectomy and tracheostomy care.
Bowel Care
Transanal irrigation systems for managing faecal incontinence and chronic constipation.
Interventional Urology
Implants, surgical slings, and urological surgery tools for treating selected urological conditions.

Show all 6 products

+ 3 more: Voice and Respiratory Care, Bowel Care, Interventional Urology

Recent updates13

Launches, partnerships and team changes from press coverage

Dec 31, 2026Product launch
Coloplast plans to launch Titan Prime, its next-generation inflatable penile implant for severe erectile dysfunction, in the U.S. market in the second half of 2026 following FDA clearance.
marketscreener.com
Sep 1, 2026Team change
Coloplast appointed Amanda Rajkumar as Chief People Officer and a member of its Executive Leadership Team, effective September 1, 2026.
biospace.com
May 1, 2026Partnership
Coloplast entered into a new innovative technology contract with Vizient for its Biatain silicone fit wound care product, formalizing a commercial collaboration for Vizient member healthcare providers.
marketscreener.com
May 1, 2026Team change
Coloplast appointed Gavin Wood as its new President and CEO effective May 1, 2026, succeeding interim CEO Lars Rasmussen after the departure of former CEO Kristian Villumsen.
investing.com
May 1, 2026Award
Coloplast received Vizient's Innovative Technology contract for its Biatain Silicone Fit wound dressing, recognizing the product's unique features and potential to improve clinical care and operational efficiency for healthcare providers.
Dec 4, 2025Team change
At Coloplast, long-time board member Lars Rasmussen left the board, while Niels B. Christiansen joined as a new board member, and Jette Nygaard-Andersen was elected Chairman with Niels Peter Louis-Hansen as Deputy Chairman following the 2025 AGM.
globenewswire.com
Dec 4, 2025Team change
Coloplast interim CEO Lars Rasmussen will not stand for re-election and will step down from the Board at the Dec 4, 2025 AGM, while continuing as interim CEO until a new CEO is appointed.
globenewswire.com
Dec 1, 2025Product launch
Coloplast introduced an upgraded hydrophilic antimicrobial urinary catheter aimed at long-term care facilities, offering extended efficacy against multidrug-resistant bacteria and contributing to lower infection rates.
einpresswire.com
Sep 3, 2025Partnership
Coloplast signed a distribution agreement with Medtronic to expand in the Asia-Pacific region.
einpresswire.com
Jul 21, 2025Product launch
Coloplast recently launched the Luja Urinary Catheter, demonstrating its commitment to innovation in urinary incontinence devices.
globenewswire.com
May 5, 2025Team change
Coloplast A/S CEO Kristian Villumsen has stepped down from his position as of today, with Lars Rasmussen appointed as interim CEO while the company searches for a new permanent CEO. Additionally, Jette Nygaard-Andersen has been appointed interim Chair of the Board during Rasmussen's tenure as interim CEO.
globenewswire.com
Mar 31, 2024Product launch
Coloplast launched the Titan Touch Penile Implant in the U.S., focusing on improved ease of use.
einpresswire.com
Mar 1, 2024Product launch
Coloplast began a clinical trial in March 2024 for its Biatain Silicone Ag Xtra dressing in Canada, focusing on advanced biofilm management in MRSA-colonized burn wounds, as part of its product development and market introduction efforts.
globenewswire.com

Show all 13 updates

About Coloplast

Products: Ostomy Care, Continence Care, Advanced Wound Dressings, Voice and Respiratory Care, Bowel Care, Interventional Urology
Leadership: Amanda Rajkumar, Chief People OfficerGavin Wood, President and CEOLars Rasmussen, Interim CEOSoren Koch, SW Process Engineer
Focus areas: Health Care, manufacturing, medical device
Headquarters: Denmark
Founded: 1957
Employees: 11–50
Patents granted: 1285 (Crunchbase)
Trademarks: 502